Karin Rodland holds a joint appointment as an Affiliate Professor of Cell, Developmental, and Cancer Biology at OHSU, and as a Laboratory Fellow at Pacific Northwest National Laboratory. She is currently the PNNL co-Director of the OHSU-PNNL Precision Medicine Innovation CoLaboratory, a joint effort dedicated to improving patient outcomes through the integration of cutting-edge technologies in integrated omics, imaging, and data analysis while advancing the goals of precision medicine.  Dr. Rodland's research focuses on signal transduction pathways that regulate proliferation in normal and malignant cells. She was the first to recognize the role of the calcium-sensing receptor in modulating proliferation in response to small molecules in the extracellular environment. Since joining PNNL, she has adopted a systems biology approach to signal transduction and has become a recognized expert in the field of proteomics and cancer biomarkers. Dr. Rodland was named a Fellow of the American Association for the Advancement of Science in 2011 and currently serves on the US HUPO Board of Directors and the FASEB Science Policy Committee.